Atrial Fibrillation with Rapid Ventricular Response: Definition, Diagnosis, and Treatment

Definition and ECG Characteristics

Atrial fibrillation with rapid ventricular response (AFib with RVR) is defined as AFib with an irregular ventricular rate typically exceeding 100 beats per minute, characterized on ECG by absent P waves, irregular R-R intervals, and fibrillatory waves, with the ventricular rate determined by AV nodal conduction properties and autonomic tone, as stated by the European Heart Journal and the Journal of the American College of Cardiology 1, 2, 3
The European Society of Cardiology recommends that AFib with RVR is a supraventricular tachyarrhythmia with specific features, including replacement of consistent P waves by rapid oscillations or fibrillatory waves, irregular R-R intervals, and absence of distinct repeating P waves 1, 2, 3, 4
The American College of Cardiology states that the ventricular rate typically exceeds 100 bpm, often 120-160 bpm in untreated states, and extremely rapid rates exceeding 200 bpm suggest the presence of an accessory pathway (Wolff-Parkinson-White syndrome) 1, 2, 4

The American Heart Association recommends that hemodynamically unstable patients require immediate synchronized electrical cardioversion, and instability includes symptomatic hypotension, acute heart failure or pulmonary edema, ongoing chest pain/acute coronary syndrome, and altered mental status, as stated by the Journal of the American College of Cardiology 3, 6

The European Society of Cardiology recommends that for stable patients, initiate rate control medications promptly rather than waiting for spontaneous conversion, and beta-blockers or non-dihydropyridine calcium channel blockers are first-line therapy 6, 7
The American College of Cardiology states that the target heart rate is <110 bpm at rest, and a stricter target of 60-80 bpm is reserved only for patients with persistent symptoms or suspected tachycardia-induced cardiomyopathy 6, 7

The American Heart Association recommends that in patients with Wolff-Parkinson-White syndrome with pre-excited AFib, IV procainamide or ibutilide is recommended rather than AV nodal blocking agents, and beta-blockers and calcium channel blockers are contraindicated 6
The European Society of Cardiology states that in heart failure with reduced ejection fraction, beta-blockers remain first-line due to prognostic benefits, and amiodarone is preferred when beta-blockers are contraindicated or ineffective 6, 7

The American College of Cardiology recommends that obligatory evaluation includes resting heart rate measurement, 24-hour Holter monitoring, and exercise testing in symptomatic patients to assess rate control adequacy, and uncontrolled tachycardia ≥130 bpm can lead to tachycardia-induced cardiomyopathy 7